Article

Facing Drug Sourcing Challenges in Clinical Trials? Our Experts Break It Down

In clinical trials, sourcing the right drugs isn’t just a procurement task – it’s a make-or-break factor for your study’s success. From oncology to large-scale global protocols, today’s sponsors face mounting complexity: global supply chain risks, evolving and country-specific regulations, and growing pressure on timelines and budgets.

That’s why we asked our Myonex experts to share their insights on some of the most pressing drug sourcing challenges and how to overcome them.

What should you know…

In this 3-part video series, discover how Myonex helps clinical teams stay ahead with tailored sourcing strategies, global access, and reliable execution. Whether your focus is oncology, comparator supply, or global import/export, we’ve got you covered.

What should you know about sourcing drugs – especially for oncology clinical trials?

Oncology trials are complex, high-stakes, and resource-intensive. Delays or inconsistencies in comparator and commercial drug supply can derail timelines and impact patient safety.

In this video, Jodi Dennis, Associate Director Drug Sourcing at Myonex, explains how we provide reliability, agility, patient-centricity and foresight.

With over 30 years of experience, we bring together global and centralized local sourcing capabilities to ensure you access the right treatments, when and where they’re needed.

You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Unblock content Accept required service and unblock content

What should you know about supply of commercial and comparator drugs for large-scale or long-duration clinical trials?

When trials stretch across years and/or span multiple geographies, sourcing is not just about product availability – it’s about long-term reliability.

In this video, Alfie Young, Senior Client Account Manager Drug Sourcing at Myonex, shares how we support consistency over time, across borders, and through changing regulations.

From hybrid sourcing models – including CTRx^®– to proactive risk planning, we help sponsors avoid protocol disruptions and build a more resilient trial supply strategy.

You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Unblock content Accept required service and unblock content

What should you know about import/export of commercial drugs in global clinical trials?

Global trials face one of the most underestimated hurdles: navigating the maze of import/export regulations.

In this video, Matt Grace, Senior Director Drug Sourcing, makes you discover how Myonex helps sponsors overcome import license, and customs complexities – so shipments move smoothly across borders.

Our teams manage everything, including QP release, cold chain logistics and local regulatory alignment – so you don’t have to become an expert in every country’s rules.

You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Unblock content Accept required service and unblock content

This also means that, if required, packaging and labeling must be completed in advance, in full compliance with local regulations – a process seamlessly managed by Myonex through our integrated clinical services.

Looking for more guidance on drug sourcing in clinical trials?
At Myonex, we recognize that each trial is unique and we never apply a one-size-fits-all approach. We help sponsors and CROs build sourcing strategies that are efficient, reliable, and tailored to trial realities.

Let’s simplify complexity and advance medicine together.

Explore Drug & Ancillary Sourcing Services